Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Shares Outstanding (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) posted Shares Outstanding of 143.19 million for the quarter ended Jun 30, 2026, down 0.2% from 143.53 million a year earlier and unchanged from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Shares Outstanding (2017 - 2026) Analysis & Trends

Since the quarter ended Mar 31, 2018, Takeda Pharmaceutical has reported Shares Outstanding for 29 quarters.

  • Annual Shares Outstanding shows a five-year compound annual growth rate of 0.2% (years ended Mar 2021 to Mar 2026).
  • In prior years, Takeda Pharmaceutical's Shares Outstanding was 143.53 million in the year ended Mar 31, 2025 (+0.9%), 142.22 million in the year ended Mar 31, 2024 (+0.8%), 141.07 million in the year ended Mar 31, 2023 (-0.7%) and 142.14 million in the year ended Mar 31, 2022 (+0.1%).
  • Quarterly Shares Outstanding has run from a low of 141.07 million in the quarter ended Mar 31, 2023 to a high of 143.53 million in the quarter ended Dec 31, 2025 over five years.
  • On a year-over-year basis, Shares Outstanding increased in six of the last eight quarters, with growth averaging 0.6%.
  • The strongest year-over-year quarter for Shares Outstanding in the past five years was the quarter ended Dec 31, 2025, with growth of 0.9%; the weakest was the quarter ended Mar 31, 2023, with a decline of 0.7%.
  • According to Business Quant data, Shares Outstanding for the three prior quarters was 143.19 million (quarter ended Mar 31, 2026), 143.53 million (quarter ended Dec 31, 2025) and 143.53 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn 143.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143.19 Mn
Mar 31, 2026 143.19 Mn
Dec 31, 2025 143.53 Mn
Sep 30, 2025 143.53 Mn
Jun 30, 2025 143.53 Mn
Mar 31, 2025 143.53 Mn
Dec 31, 2024 142.22 Mn
Sep 30, 2024 142.22 Mn
Jun 30, 2024 142.22 Mn
Mar 31, 2024 142.22 Mn
Dec 31, 2023 141.07 Mn
Sep 30, 2023 141.07 Mn
Jun 30, 2023 141.07 Mn
Mar 31, 2023 141.07 Mn
Dec 31, 2022 142.14 Mn
Sep 30, 2022 142.14 Mn
Jun 30, 2022 142.14 Mn
Mar 31, 2022 142.14 Mn
Jun 30, 2021 142.00 Mn
Mar 31, 2021 142.00 Mn
API Access

Takeda Pharmaceutical Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TAK&period=max&api_key=YOUR_API_KEY